4 active not recruiting. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 4 |
| Phase 2 | 2 | Active not recruiting 2 |
Follow Control: new trials by email Literature Review of Control trials Research Report on Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation TSC-101, Control - AML, MDS | Phase 3 | Active not recruiting | TScan Therapeutics, Inc. | 310 | 2026-06-18 | 2026-10-05 |
| A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP rAAV2tYF-GRK1-hRPGRco, Control - X-Linked Retinitis Pigmentosa | Phase 2 / Phase 3 | Active not recruiting | Beacon Therapeutics | 85 | 2024-03-14 | 2026-04-07 |
| Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care Platelet-Rich Plasma-Fibrin Glue, Repairing Gel, Repairing Gel and Platelet-Rich Plasma-Fibrin Glue - Wounds and Injuries | Phase 2 / Phase 3 | Active not recruiting | Mashhad University of Medical Sciences | 40 | 2023-08-20 | 2026-05-06 |
| Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth Sulfadoxine-pyrimethamine treatment twice during pregnancy, Sulfadoxine-pyrimethamine at 4-week intervals, Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twice - Malaria, Sexually Transmitted Diseases | Phase 3 | Active not recruiting | Tampere University | 1320 | 2003-12-01 | 2025-03-25 |
Malaria (1) · Premature Birth (1) · Retinal Degeneration (1) · Sexually Transmitted Diseases (1) · Wounds and Injuries (1)
Beacon Therapeutics (1) · Mashhad University of Medical Sciences (1) · TScan Therapeutics, Inc. (1) · Tampere University (1)
United States (2) · Australia (1) · Canada (1) · Iran (1) · Malawi (1) · United Kingdom (1)
Carrie Reichley (1) · Daryoush Hamidi Alamdari (1) · Daryoush Hamidi Alamdari, Ph.D (1) · Kenneth M Maleta, MBBS, PhD (1) · Per Ashorn, MD, PhD (1) · Shrikanta Chattopadhyay, MD (1)
PMID 20350189, PMID 20925928, PMID 21118924, PMID 22299027, PMID 22829919, PMID 23198734, PMID 23432801, PMID 24225354, PMID 34479861, PMID 39324693, PMID 40547876